Abstract
Acute medication adherence is essential to manage chronic, episodic disorders, including headache. This paper describes the development of a measure of acute medication self-efficacy for headache (AMSE-H). Phase 1: 14 AMSE-H items were generated through qualitative interviews with 21 patients and 15 clinical headache experts. Phase 2: Researchers selected 7 AMSE-H items by examining item performance in 35 headache patients. Phase 3: Migraine patients (n = 161) completed the AMSE-H, and measures of outcome expectancies, perceived access to medication, headache management self-efficacy (n = 58) and a 1-week AMSE-H re-test (n = 103). Content validity was established through input of multiple stakeholder groups during item generation. PCA identified two components: cross-episode self-efficacy (eigenvalue = 3.4) and Episode-Specific Self-Efficacy (eigenvalue = 1.0). These subscales are internally consistent (.73–.80), have low 1-week test–retest reliability (rs = .52–.66), and demonstrated solid construct and discriminant validity. The AMSE-H is brief, theory-driven, focused, socially valid measure acceptable to both patients and providers.
Similar content being viewed by others
References
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191–215.
Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W.H. Freeman.
Bandura, A. (2006). Guide for creating self-efficacy scales. In F. Pajares & T. Urdan (Eds.), Self-efficacy beliefs of adolescents. Greenwich, CT: Information Age Publication Inc.
Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., & Martelletti, P. (2012). Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS). The Journal of Headache and Pain, 13, 361–378.
Brantlinger, E., Jimenez, R., Klingner, J., Pugach, M., & Richardson, V. (2005). Qualitative studies in special education. Exceptional Children, 71, 195.
Brus, H., van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (1999). Determinants of compliance with medication in patients with rheumatoid arthritis: The importance of self-efficacy expectations. Patient Education and Counseling, 36, 57–64.
Burch, R. C., Loder, S., Loder, E., & Smitherman, T. A. (2015). The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache, 55, 21–34.
Burkhart, P. V., & Sabate, E. (2003). Adherence to long-term therapies: Evidence for action. Journal of Nursing Scholarship, 35, 207.
Cady, R. K., Farmer, K., Beach, M. E., & Tarrasch, J. (2008). Nurse-based education: An office-based comparative model for education of migraine patients. Headache, 48, 564–569.
DiMatteo, M. R. (2004). Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42, 200–209.
Dunbar-Jacob, J., Erlen, J. A., Schlenk, E. A., Ryan, C. M., Sereika, S. M., & Doswell, W. M. (2000). Adherence in chronic disease. Annual Review of Nursing Research, 18, 48–90.
Ericsson, K. A., & Simon, H. A. (1993). Protocol analysis: Verbal reports as data (Revised Edition ed.). Cambridge, MA: The MIT Press.
Fernandez, S., Chaplin, W., Schoenthaler, A. M., & Ogedegbe, G. (2008). Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. Journal of Behavioral Medicine, 31, 453–462.
Foley, K., Cady, R., Martin, V., Adelman, J., Diamond, M., Bell, C., & Hu, X. (2005). Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine. Headache: The Journal of Head and Face Pain, 45, 538–545.
Forsyth, A. D., & Carey, M. P. (1998). Measuring self-efficacy in the context of HIV risk reduction: Research challenges and recommendations. Health Psychology, 17, 559–568.
French, D. J., Holroyd, K. A., Pinnell, C., Malinoski, P. T., ODonnell, F. J., & Hill, K. R. (2000). Perceived self-efficacy and headache-related disability. Headache, 40, 647–656.
Gallagher, R., & Kunkel, R. (2003). Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment. Headache: The Journal of Head and Face Pain, 43, 36–43.
Headache Classification Committee of the International Headache Society (IHS). (2013). The International classification of headache disorders, 3rd edition (beta version). Cephalalgia, 33, 629–808.
Holroyd, K. A., Holm, J. F., Penzien, D. B., Cordingley, G. E., Hursey, K. G., Martin, N. J., & Theofanous, A. (1989). Long-term maintenance of improvements achieved with (abortive) pharmacological and nonpharmacological treatments for migraine: Preliminary findings. Biofeedback and Self Regulation, 14, 301–308.
Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E., & Chesney, M. A. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project. AIDS Patient Care and STDs, 17, 645–656.
Johnston, M. M., & Rapoport, A. M. (2010). Triptans for the management of migraine. Drugs, 70, 1505–1518.
Kalichman, S. C., Cain, D., Fuhrel, A., Eaton, L., Di Fonzo, K., & Ertl, T. (2005). Assessing medication adherence self-efficacy among low-literacy patients: Development of a pictographic visual analogue scale. Health Education Research, 20, 24–35.
Katic, B. J., Krause, S. J., Tepper, S. J., Hu, H. X., & Bigal, M. E. (2010). Adherence to acute migraine medication: What does it mean, why does it matter? Headache, 50, 117–129.
Lanteri-Minet, M., Duru, G., Mudge, M., & Cottrell, S. (2011). Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review. Cephalalgia, 31, 837–850.
Lipton, R. B., Stewart, W. F., Sawyer, J., & Edmeads, J. (2001). Clinical utility of an instrument assessing migraine disability: The Migraine Disability Assessment (MIDAS) Questionnaire. Headache, 41, 854–861.
Malik, S. N., Hopkins, M., Young, W. B., & Silberstein, S. D. (2006). Acute migraine treatment: Patterns of use and satisfaction in a clinical population. Headache, 46, 773–780.
Marks, R., Allegrante, J., & Lorig, K. (2005). A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: Implications for health education practice. Health Promotion Practice, 6, 37–43.
McLaughlin, G. (1969). SMOG grading: A new readability formula. Journal of Reading, 12, 639–646.
Miller, W., & Rollnick, S. (1991). Motivational interviewing: Preparing people for change. New York: Guilford Press.
Nicholson, R. A., Chibnall, J. T., Ng-Mak, D., Banks, J. W., & Smith, T. R. (2011a). Why wait? Reasons that patients delay taking a triptan during individual migraine attacks. Headache, 51, S6–S7.
Nicholson, R. A., Ng-Mak, D., Chibnall, J. T., Banks, J. W., & Smith, T. R. (2011). To use or not to use: Reasons for and consequences of not using a triptan during individual migraine attacks. Paper presented at the Annual Scientific Meeting of the American Headache Society, Washington, DC.
Nicholson, R. A., & Smith, T. R. (2015). Longtidunal real and near-time assessment of acute medication adherence during migraine attacks. Paper presented at the Annual Scientific Meeting of the American Headache Society, Washington, DC.
Nicholson, R. A., Smith, T. R., Banks, J. W., Chibnall, J. T., Holroyd, K. A., & Kreuter, M. K. (2010). Effectiveness of a tailored migraine management program. Paper presented at the European Headache and Migraine Trust International Congress, Nice, France.
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill Inc.
Ogedegbe, G., Mancuso, C. A., Allegrante, J. P., & Charlson, M. E. (2003). Development and evaluation of a medication adherence self-efficacy scale in hypertensive African–American patients. Journal of Clinical Epidemiology, 56, 520–529.
Packard, R. C., & O’Connell, P. (1986). Medication compliance among headache patients. Headache, 26, 416–419.
Peters, M., Abu-Saad, H. H., Vydelingum, V., Dowson, A., & Murphy, M. (2003). Patients’ decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia, 23, 833–841.
Resnick, B., Wehren, L., & Orwig, D. (2003). Reliability and validity of the self-efficacy and outcome expectations for osteoporosis medication adherence scales. Orthopaedic Nursing, 22, 139–147.
Risser, J., Jacobson, T. A., & Kripalani, S. (2007). Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. Journal of Nursing Measurement, 15, 203–219.
Rudy, B. J., Murphy, D. A., Harris, D. R., Muenz, L., & Ellen, J. (2009). Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: A study of prevalence and interactions. AIDS Patient Care and STDs, 23, 185–194.
Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39, 1151–1162.
Schwartz, I., & Baer, D. (1991). Social validity assessments: Is current practice state of the art? Journal of Applied Behavior Analysis, 24, 16.
Seidman, I. (2006). Interviewing as qualitative research: A guide for researchers in education and the social sciences (3rd ed.). New York: Teachers College Press.
Seng, E. K., & Holroyd, K. A. (2013). Optimal use of acute headache medication: A qualitative examination of behaviors and barriers to their performance. Headache, 53, 1438–1450. doi:10.1111/head.12157
Silberstein, S. (2000). Practice Parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Neurology, 55, 754–762.
Turner, R. R., Quittner, A. L., Parasuraman, B. M., Kallich, J. D., & Cleeland, C. S. (2007). Patient-reported outcomes: Instrument development and selection issues. Value in Health, 10, S86–S93.
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., & Memish, Z. A. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163–2196.
Worthington, I., Pringsheim, T., Gawel, M. J., Gladstone, J., Cooper, P., Dilli, E., & Becker, W. J. (2013). Canadian Headache Society Guideline: Acute drug therapy for migraine headache. Canadian Journal of Neurological Sciences, 40, S1–S80.
Acknowledgments
We would like to acknowledge the invaluable assistance of Dr. Frank O’Donnell in data collection and conceptualization, Drs. Julie Suhr, Bernadette Heckman, George Johanson and John Hitchcock for serving as members on the dissertation committee for this project, and members of the Ohio Headache Association for enthusiastic support of this project.
Funding
This research was funded through a Research Award granted to the first author from the Ohio Headache Association.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Elizabeth K. Seng, Robert A. Nicholson and Kenneth A. Holroyd have no conflicts of interest to report.
Human and animal rights and Informed Consent
All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Appendix: Acute medication self-efficacy-headache
Appendix: Acute medication self-efficacy-headache
Taking medication for your headache is a skill, just like anything else you learn to do. If you are learning to play baseball, you may feel very confident you can hit a single, but less confident you can hit a home run. Or, if you are learning to play the piano, you may feel confident to play a song with one hand, but less confident to play with both hands. In the same way, you may feel confident about taking medication for your headache at some times under certain circumstances, but less confident at other times and under different circumstances.
These questions ask about your confidence to take “acute” headache medication. You take acute medication when a headache happens (NOT every day to prevent headaches). What type(s) of acute headache medication do you take?
Rights and permissions
About this article
Cite this article
Seng, E.K., Nicholson, R.A. & Holroyd, K.A. Development of a measure of self-efficacy for acute headache medication adherence. J Behav Med 39, 1033–1042 (2016). https://doi.org/10.1007/s10865-015-9683-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10865-015-9683-9